US Broker Ratings

Beta Bionics, Inc. (BBNX) Stock Analysis: A 25% Potential Upside Amidst Strong Revenue Growth

Beta Bionics, Inc. (NASDAQ: BBNX), a commercial-stage medical device company, is making waves in the healthcare sector with its innovative solutions designed to improve the lives..

Delcath Systems, Inc. (DCTH) Stock Analysis: Unveiling a 62.71% Potential Upside in the Medical Devices Sector

As investors search for promising opportunities within the healthcare sector, Delcath Systems, Inc. (NASDAQ: DCTH) stands out with a compelling potential upside of 62.71%, making it..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Evaluating a 29.48% Upside Potential

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, presents a compelling investment case for those interested in the biotechnology sector. Specializing in novel therapeutics for..

SI-BONE, Inc. (SIBN) Stock Analysis: 18% Potential Upside Backed by Strong Buy Ratings

SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the medical device sector, is drawing significant attention from investors due to its innovative solutions in the realm..

LifeMD, Inc. (LFMD) Stock Analysis: Potential Upside of 274.42% Captivates Investors

In the ever-evolving landscape of healthcare, LifeMD, Inc. (NASDAQ: LFMD) stands out as a compelling prospect for investors keen on capitalizing on the telehealth boom. With..

ArriVent BioPharma, Inc. (AVBP) Investor Outlook: Strong Buy Ratings and a Promising 16.15% Upside

ArriVent BioPharma, Inc. (AVBP), a rising star in the biotechnology sector, is capturing the attention of investors with its ambitious pipeline and a market cap of..

Savara, Inc. (SVRA) Stock Analysis: Exploring a 143% Upside Potential in Biotech

Savara, Inc. (SVRA), a promising player in the biotech sector, is capturing investor attention with its significant potential upside. The company, headquartered in Yardley, Pennsylvania, focuses..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unlocking a 42.94% Potential Upside in the Specialty Drug Market

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) has emerged as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..

uniQure N.V. (QURE) Stock Analysis: Investor Outlook Highlights 161% Potential Upside

uniQure N.V. (NASDAQ: QURE), a leading biotechnology firm based in the Netherlands, is making significant strides in the healthcare sector by focusing on gene therapies for..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Gem with 21.58% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) stands at the forefront of the biotechnology sector, offering a blend of innovation and potential that is capturing the attention of investors...

OrthoPediatrics Corp. (KIDS) Stock Analysis: Capturing Growth Potential with a 15.4% Revenue Surge

OrthoPediatrics Corp. (NASDAQ: KIDS), a leader in the pediatric orthopedic device sector, is making waves in the healthcare industry. With a focus on designing and marketing..

iRadimed Corporation (IRMD): Investor Outlook Reveals 34.64% Potential Upside for This Medical Device Innovator

iRadimed Corporation (NASDAQ: IRMD) stands out in the healthcare sector with its focus on MRI-compatible medical devices. As an innovator in this niche market, the company..

Oculis Holding AG (OCS) Stock Analysis: A Compelling 359% Upside Awaits Investors

Investors in the biotechnology sector may find Oculis Holding AG (NASDAQ: OCS) an intriguing opportunity with its remarkable potential upside. Based in Zug, Switzerland, Oculis is..

CorMedix Inc. (CRMD) Stock Analysis: Unpacking the Impressive 89.30% Potential Upside

Investors with a keen eye on the healthcare sector might want to take a closer look at CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company specializing in..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Unpacking a Potential 111.78% Upside

Arcus Biosciences, Inc. (NASDAQ: RCUS) stands as a noteworthy player in the biotechnology sector, specifically focusing on the development of innovative cancer therapies. With a market..

Enliven Therapeutics, Inc. (ELVN)

⚠️ No article content returned.

..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unpacking a Potential 379% Upside for Investors

Niagen Bioscience, Inc. (NASDAQ: NAGE) presents an intriguing opportunity for investors with its impressive potential upside of 379.50%, according to analyst ratings. Operating within the Consumer..

Evolus, Inc. (EOLS) Stock Analysis: A 102% Upside Potential in the Cosmetic Healthcare Sector

Evolus, Inc. (NASDAQ: EOLS) is catching the eyes of investors with a compelling potential upside of over 102%, according to recent analyst ratings. This performance beauty..

CeriBell, Inc. (CBLL) Stock Analysis: Strong Buy Ratings Signal Promising Growth in Medical Device Sector

CeriBell, Inc. (CBLL), a key player in the healthcare sector, is capturing investor attention with its innovative medical devices and a strong buy sentiment among analysts...

Geron Corporation (GERN) Stock Analysis: Potential 276% Upside Ignites Investor Interest

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company specializing in oncology therapeutics, has been making waves in the healthcare sector. Despite the stock’s modest current price of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds